Transforming Contraception and Oncofertility with AMH Insights – SSR
The Society for the Study of Reproduction (SSR) shared a post on LinkedIn:
“We are thrilled to announce the upcoming Roger V. Short Lecture featuring David Pépin at Harvard Medical School and 2025 Medal Recipient.
While reproductive innovation has remained largely unchanged for decades, Dr. Pépin’s lab is unlocking the power of Anti-Müllerian Hormone (AMH) to transform:
Contraception: Developing non-hormonal, long-term alternatives (including gene therapy in felines!).
Oncofertility: Protecting the ovarian reserve and uterine integrity during chemotherapy.
Aging: Understanding how ‘follicle pausing’ can improve long-term women’s health.
- When: Friday, March 6, 2026
- Time: 4:00 PM – 5:00 PM
- Where: Zoom
Don’t miss this deep dive into the translational pipeline of ovarian biology.”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Jun 23, 2026, 15:37Sergio Haimovich: A Septate Uterus Is Not Only a Fertility Issue But Also Influences Fetus Growth
-
Jun 23, 2026, 15:32Akansha Negi: AMH – A Number That Guides Treatment, Not a Number That Defines Fertility
-
Jun 23, 2026, 14:51UOG Journal Special Issue to Spotlight Advances in Congenital Heart Disease Research – ISUOG
-
Jun 23, 2026, 14:39Gynaecological Ultrasound Takes Centre Stage at Pre-ISUOG Educational Course – Gynaia
-
Jun 23, 2026, 12:39Christopher Robinson: The Pelosi Cesarean Delivery Technique – Pfannenstiel Incision
-
Jun 23, 2026, 12:36Harald Krentel: Stockholm Hosts Leading Experts in Robotic Gynecological Surgery
-
Jun 23, 2026, 11:36Fertility Strategy For Women with Polycystic Ovary Syndrome – IVF or IVM – MEFS
-
Jun 23, 2026, 11:22Contraceptive Strategies for Reducing the Risk of Reproductive Cancers – IJGO
-
Jun 23, 2026, 11:20Bringing C-RHI Back, A Story of Persistence and Professional Pride – ASRM